<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="23478" end="23483" sStart="23464" offset="14" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="This suggests using YHL as the outcome measure in clinical trials involving obese or underweight older adults, and discouraging trials that address older adults who are merely overweight." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="23308" end="23313" sStart="null" offset="0" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Using either YOL or YHL, however, we found no excess risk for older adults who would be classified as 'overweight' by the NHLBI guidelines." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="20648" end="20653" sStart="null" offset="251" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Clinical trials whose objective was to make the underweight as healthy as their normal-weight peers (presumably by addressing the underlying conditions that caused the low weight) could be performed efficiently using either YOL or YHL as the outcome measure." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19550" end="19554" sStart="null" offset="38" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Weight or weight change are sometimes used as the outcome in evaluations of interventions such as diet or exercise programs." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17771" end="17776" sStart="null" offset="112" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="As mentioned above, we repeated these analyses excluding the persons with partially estimated data, and using two different ways of coding YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17388" end="17393" sStart="null" offset="89" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Trials to make obese women comparable to normal women could be evaluated using YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17250" end="17255" sStart="null" offset="145" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9362" end="9367" sStart="null" offset="113" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="We plotted mean adjusted YOL and YHL against BMI, and tested for difference among BMI groups using confidence intervals or analysis of variance." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="6513" end="6517" sStart="null" offset="37" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="In the primary analysis we used observed 7-year YOL and YHL when they were available, and observed 3-year YOL and YHL plus 4-year estimated YOL and YHL when they were not (about 10% of the sample)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="6302" end="6307" sStart="null" offset="230" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="For those persons, and for 70 persons in the first cohort who did not have complete data, we estimated the last 4 years of YOL and YHL from their age, sex, and health at the end of 3 years, using validated methods presented elsewhere [ 20 ] . That article showed that estimated 4-year YOL and YHL were unbiased for the African American cohort." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5860" end="5865" sStart="null" offset="230" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5648" end="5652" sStart="null" offset="18" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="4794" end="4798" sStart="null" offset="3" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="We used linear interpolation to estimate missing data when there were known values before and after the missing value, bringing the percent complete to 95% [ 18 ] ." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="2818" end="2823" sStart="null" offset="66" sid="null" wn="1" wnkey="use%2:34:01::" annotator="anfahmy" text="Extensive baseline data were collected for all subjects using a baseline home interview, an annual mail questionnaire, and annual clinic examinations." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="976" end="985" sStart="null" offset="12" sid="r8.suggest.v.0029" wn="1" wnkey="suggest%2:32:00::" annotator="veweser" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="976" end="985" sStart="null" offset="12" sid="r8.suggest.v.0029" wn="1" wnkey="suggest%2:32:00::" annotator="jeneale" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="976" end="985" sStart="null" offset="12" sid="r8.suggest.v.0029" wn="1" wnkey="suggest%2:32:00::" annotator="cgozo" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="976" end="985" sStart="null" offset="12" sid="r8.suggest.v.0029" wn="1" wnkey="suggest%2:32:00::" annotator="brubin" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16324" end="16329" sStart="null" offset="182" sid="null" wn="2147483646" wnkey="null" annotator="sophiavv" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5557" end="5561" sStart="null" offset="118" sid="r7.poor.j.0401" wn="4" wnkey="poor%3:00:02::" annotator="veweser" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between fair or poor health and death, since all are considered 'not healthy'." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5557" end="5561" sStart="null" offset="118" sid="r7.poor.j.0401" wn="4" wnkey="poor%3:00:02::" annotator="jeneale" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between fair or poor health and death, since all are considered 'not healthy'." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="7378" end="7382" sStart="null" offset="141" sid="r7.poor.j.0760" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="cgozo" text="Self-reported covariates include age, gender, smoking (never or former), history of arthritis, cancer, diabetes, fair or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="4403" end="4407" sStart="null" offset="318" sid="r7.poor.j.0196" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="cgozo" text="YHL is the number of years in which the person was 'healthy', and is similar in concept to quality-adjusted life-years, healthy year equivalents, or active life expectancy [ 14 ] . We based YHL on self-rated health (is your health excellent, very good, good, fair, or poor?)" />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="22025" end="22029" sStart="null" offset="49" sid="r7.poor.j.0783" wn="4" wnkey="poor%3:00:02::" annotator="brubin" text="A person who is depressed because of a poor self-image related to obesity or who has osteo-arthritis related to obesity and limits to activities to successfully avoid pain would surely have worse EVGFP than others, based on results from many studies." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="10561" end="10565" sStart="null" offset="39" sid="r7.poor.j.0507" wn="4" wnkey="poor%3:00:02::" annotator="brubin" text="Of the 22% who were unhealthy (fair or poor) at baseline, about 24% were healthy 7 years later." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="23988" end="23992" sStart="null" offset="65" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="EVGFP Is your health excellent, very good, good, fair or poor?" />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22025" end="22029" sStart="null" offset="49" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="A person who is depressed because of a poor self-image related to obesity or who has osteo-arthritis related to obesity and limits to activities to successfully avoid pain would surely have worse EVGFP than others, based on results from many studies." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="10561" end="10565" sStart="null" offset="39" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="Of the 22% who were unhealthy (fair or poor) at baseline, about 24% were healthy 7 years later." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="7378" end="7382" sStart="null" offset="141" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="Self-reported covariates include age, gender, smoking (never or former), history of arthritis, cancer, diabetes, fair or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5557" end="5561" sStart="null" offset="118" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between fair or poor health and death, since all are considered 'not healthy'." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="4403" end="4407" sStart="null" offset="318" sid="null" wn="4" wnkey="poor%3:00:02::" annotator="anfahmy" text="YHL is the number of years in which the person was 'healthy', and is similar in concept to quality-adjusted life-years, healthy year equivalents, or active life expectancy [ 14 ] . We based YHL on self-rated health (is your health excellent, very good, good, fair, or poor?)" />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18744" end="18750" sStart="null" offset="146" sid="null" wn="1" wnkey="people%1:14:00::" annotator="sophiavv" text="Since future improvements in life expectancy may be limited [ 32 ] , the greatest advances may be made by improving people's YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5338" end="5344" sStart="null" offset="6" sid="null" wn="1" wnkey="people%1:14:00::" annotator="sophiavv" text="Since people reported their health every 6 months, YHL has a reasonably continuous distribution." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16732" end="16736" sStart="null" offset="79" sid="null" wn="2147483647" wnkey="null" annotator="sophiavv" text="The effect sizes are not significantly different from zero for men, in part because there were only 42 men in the underweight category." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14807" end="14811" sStart="null" offset="125" sid="null" wn="2147483647" wnkey="null" annotator="sophiavv" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in part because of low sample size." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="14807" end="14811" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" annotator="carichter" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in &lt;b&gt;part&lt;/b&gt; because of low sample size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="1823" end="1828" sStart="null" offset="197" sid="r9.paper.n.0022" wn="5" wnkey="paper%1:10:02::" annotator="veweser" text="Clinical trials powered to detect differences in YHL would often require fewer subjects than trials to detect survival differences or cardiovascular events [ 10 ] . In this paper we study whether BMI at baseline is associated with living longer, and/or with more years of being healthy, in a cohort of older adults for whom risk factors, subclinical disease, and morbidity are well characterized." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="1823" end="1828" sStart="null" offset="197" sid="r9.paper.n.0022" wn="5" wnkey="paper%1:10:02::" annotator="cgozo" text="Clinical trials powered to detect differences in YHL would often require fewer subjects than trials to detect survival differences or cardiovascular events [ 10 ] . In this paper we study whether BMI at baseline is associated with living longer, and/or with more years of being healthy, in a cohort of older adults for whom risk factors, subclinical disease, and morbidity are well characterized." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="1823" end="1828" sStart="null" offset="197" sid="r9.paper.n.0022" wn="5" wnkey="paper%1:10:02::" annotator="brubin" text="Clinical trials powered to detect differences in YHL would often require fewer subjects than trials to detect survival differences or cardiovascular events [ 10 ] . In this paper we study whether BMI at baseline is associated with living longer, and/or with more years of being healthy, in a cohort of older adults for whom risk factors, subclinical disease, and morbidity are well characterized." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="1823" end="1828" sStart="null" offset="197" sid="r9.paper.n.0022" wn="5" wnkey="paper%1:10:02::" annotator="anfahmy" text="Clinical trials powered to detect differences in YHL would often require fewer subjects than trials to detect survival differences or cardiovascular events [ 10 ] . In this paper we study whether BMI at baseline is associated with living longer, and/or with more years of being healthy, in a cohort of older adults for whom risk factors, subclinical disease, and morbidity are well characterized." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="14667" end="14673" sStart="null" offset="106" sid="r9.normal.j.0933" wn="1" wnkey="normal%3:00:01::" annotator="veweser" text="Underweight women averaged about .25 fewer YOL than other women (p &lt; .05 compared with normal group)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22679" end="22685" sStart="null" offset="104" sid="r9.normal.j.0026" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19186" end="19192" sStart="null" offset="63" sid="r9.normal.j.0025" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="That is, women who changed from being obese to being normal would likely show changes in YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18500" end="18506" sStart="null" offset="105" sid="r9.normal.j.0024" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="In Figure 1, the overweight (as opposed to the obese) are no different from those of normal weight, suggesting that these two categories could be combined for older adults." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17348" end="17354" sStart="null" offset="49" sid="r9.normal.j.0023" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Trials to make obese women comparable to normal women could be evaluated using YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17203" end="17209" sStart="null" offset="98" sid="r9.normal.j.0022" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17026" end="17032" sStart="null" offset="23" sid="r9.normal.j.0021" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="For comparing obese to normal, only YHL for women showed a large and significant effect size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16537" end="16543" sStart="null" offset="80" sid="r9.normal.j.0020" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="The biggest effect sizes are in the first row, comparing underweight to normal." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16216" end="16222" sStart="null" offset="74" sid="r9.normal.j.0019" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15885" end="15891" sStart="null" offset="78" sid="r9.normal.j.0018" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15607" end="15613" sStart="null" offset="72" sid="r9.normal.j.0017" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="We next present the effect size for comparing each group to the normal BMI group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15414" end="15420" sStart="null" offset="67" sid="r9.normal.j.0016" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="YHL was significantly higher for women than for men in the normal and overweight groups, but the sexes had similar YHL in the underweight and obese groups." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15197" end="15203" sStart="null" offset="115" sid="r9.normal.j.0015" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="The YHL for underweight or obese women was about 4.5 years, which was significantly lower than the normal group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15029" end="15035" sStart="null" offset="15" sid="r9.normal.j.0014" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Women who were normal or overweight averaged about 4.9 YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14866" end="14872" sStart="null" offset="26" sid="r9.normal.j.0013" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Men classified as normal, overweight or obese all had about the same YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14790" end="14796" sStart="null" offset="108" sid="r9.normal.j.0012" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in part because of low sample size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14667" end="14673" sStart="null" offset="106" sid="r9.normal.j.0011" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Underweight women averaged about .25 fewer YOL than other women (p &lt; .05 compared with normal group)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="13738" end="13744" sStart="null" offset="29" sid="r9.normal.j.0010" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="5 to 20 would be considered 'normal' by the NHLBI guidelines, but had lower YOL and YHL than those with 20-24." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9536" end="9542" sStart="null" offset="112" sid="r9.normal.j.0009" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Finally we calculated the effect size for each measure, comparing each BMI subgroup to the 'normal' group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="3608" end="3614" sStart="null" offset="89" sid="r9.normal.j.0008" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="A report from the National Heart Lung and Blood Institute classifies normal weight (without reference to age) as a BMI of 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="3608" end="3614" sStart="null" offset="89" sid="r9.normal.j.0771" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="A report from the National Heart Lung and Blood Institute classifies normal weight (without reference to age) as a BMI of 18." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22679" end="22685" sStart="null" offset="104" sid="r9.normal.j.0026" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19186" end="19192" sStart="null" offset="63" sid="r9.normal.j.0025" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="That is, women who changed from being obese to being normal would likely show changes in YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18500" end="18506" sStart="null" offset="105" sid="r9.normal.j.0024" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="In Figure 1, the overweight (as opposed to the obese) are no different from those of normal weight, suggesting that these two categories could be combined for older adults." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17348" end="17354" sStart="null" offset="49" sid="r9.normal.j.0023" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Trials to make obese women comparable to normal women could be evaluated using YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17203" end="17209" sStart="null" offset="98" sid="r9.normal.j.0022" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17026" end="17032" sStart="null" offset="23" sid="r9.normal.j.0021" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="For comparing obese to normal, only YHL for women showed a large and significant effect size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16537" end="16543" sStart="null" offset="80" sid="r9.normal.j.0020" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="The biggest effect sizes are in the first row, comparing underweight to normal." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16216" end="16222" sStart="null" offset="74" sid="r9.normal.j.0019" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15885" end="15891" sStart="null" offset="78" sid="r9.normal.j.0018" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15607" end="15613" sStart="null" offset="72" sid="r9.normal.j.0017" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="We next present the effect size for comparing each group to the normal BMI group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15414" end="15420" sStart="null" offset="67" sid="r9.normal.j.0016" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="YHL was significantly higher for women than for men in the normal and overweight groups, but the sexes had similar YHL in the underweight and obese groups." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15197" end="15203" sStart="null" offset="115" sid="r9.normal.j.0015" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="The YHL for underweight or obese women was about 4.5 years, which was significantly lower than the normal group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15029" end="15035" sStart="null" offset="15" sid="r9.normal.j.0014" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Women who were normal or overweight averaged about 4.9 YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14866" end="14872" sStart="null" offset="26" sid="r9.normal.j.0013" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Men classified as normal, overweight or obese all had about the same YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14790" end="14796" sStart="null" offset="108" sid="r9.normal.j.0012" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in part because of low sample size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14667" end="14673" sStart="null" offset="106" sid="r9.normal.j.0011" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Underweight women averaged about .25 fewer YOL than other women (p &lt; .05 compared with normal group)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="13738" end="13744" sStart="null" offset="29" sid="r9.normal.j.0010" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="5 to 20 would be considered 'normal' by the NHLBI guidelines, but had lower YOL and YHL than those with 20-24." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9536" end="9542" sStart="null" offset="112" sid="r9.normal.j.0009" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="Finally we calculated the effect size for each measure, comparing each BMI subgroup to the 'normal' group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="3608" end="3614" sStart="null" offset="89" sid="r9.normal.j.0008" wn="3" wnkey="normal%3:00:03::" annotator="cgozo" text="A report from the National Heart Lung and Blood Institute classifies normal weight (without reference to age) as a BMI of 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="15197" end="15203" sStart="null" offset="115" sid="r9.normal.j.0864" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="The YHL for underweight or obese women was about 4.5 years, which was significantly lower than the normal group." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="15029" end="15035" sStart="null" offset="15" sid="r9.normal.j.0832" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Women who were normal or overweight averaged about 4.9 YHL." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="17203" end="17209" sStart="null" offset="98" sid="r9.normal.j.0344" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="15885" end="15891" sStart="null" offset="78" sid="r9.normal.j.0212" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22679" end="22685" sStart="null" offset="104" sid="r9.normal.j.0026" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19186" end="19192" sStart="null" offset="63" sid="r9.normal.j.0025" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="That is, women who changed from being obese to being normal would likely show changes in YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18500" end="18506" sStart="null" offset="105" sid="r9.normal.j.0024" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="In Figure 1, the overweight (as opposed to the obese) are no different from those of normal weight, suggesting that these two categories could be combined for older adults." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17348" end="17354" sStart="null" offset="49" sid="r9.normal.j.0023" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Trials to make obese women comparable to normal women could be evaluated using YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17203" end="17209" sStart="null" offset="98" sid="r9.normal.j.0022" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17026" end="17032" sStart="null" offset="23" sid="r9.normal.j.0021" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="For comparing obese to normal, only YHL for women showed a large and significant effect size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16537" end="16543" sStart="null" offset="80" sid="r9.normal.j.0020" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="The biggest effect sizes are in the first row, comparing underweight to normal." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16216" end="16222" sStart="null" offset="74" sid="r9.normal.j.0019" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15885" end="15891" sStart="null" offset="78" sid="r9.normal.j.0018" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15607" end="15613" sStart="null" offset="72" sid="r9.normal.j.0017" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="We next present the effect size for comparing each group to the normal BMI group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15414" end="15420" sStart="null" offset="67" sid="r9.normal.j.0016" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="YHL was significantly higher for women than for men in the normal and overweight groups, but the sexes had similar YHL in the underweight and obese groups." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15197" end="15203" sStart="null" offset="115" sid="r9.normal.j.0015" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="The YHL for underweight or obese women was about 4.5 years, which was significantly lower than the normal group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15029" end="15035" sStart="null" offset="15" sid="r9.normal.j.0014" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Women who were normal or overweight averaged about 4.9 YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14866" end="14872" sStart="null" offset="26" sid="r9.normal.j.0013" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Men classified as normal, overweight or obese all had about the same YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14790" end="14796" sStart="null" offset="108" sid="r9.normal.j.0012" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in part because of low sample size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14667" end="14673" sStart="null" offset="106" sid="r9.normal.j.0011" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Underweight women averaged about .25 fewer YOL than other women (p &lt; .05 compared with normal group)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="13738" end="13744" sStart="null" offset="29" sid="r9.normal.j.0010" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="5 to 20 would be considered 'normal' by the NHLBI guidelines, but had lower YOL and YHL than those with 20-24." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9536" end="9542" sStart="null" offset="112" sid="r9.normal.j.0009" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Finally we calculated the effect size for each measure, comparing each BMI subgroup to the 'normal' group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="3608" end="3614" sStart="null" offset="89" sid="r9.normal.j.0008" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="A report from the National Heart Lung and Blood Institute classifies normal weight (without reference to age) as a BMI of 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="22679" end="22685" sStart="null" offset="104" sid="r9.normal.j.0882" wn="3" wnkey="normal%3:00:03::" annotator="anfahmy" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="13738" end="13744" sStart="null" offset="29" sid="r9.normal.j.0566" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="5 to 20 would be considered 'normal' by the NHLBI guidelines, but had lower YOL and YHL than those with 20-24." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22679" end="22685" sStart="null" offset="104" sid="r9.normal.j.0026" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19186" end="19192" sStart="null" offset="63" sid="r9.normal.j.0025" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="That is, women who changed from being obese to being normal would likely show changes in YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18500" end="18506" sStart="null" offset="105" sid="r9.normal.j.0024" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="In Figure 1, the overweight (as opposed to the obese) are no different from those of normal weight, suggesting that these two categories could be combined for older adults." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17348" end="17354" sStart="null" offset="49" sid="r9.normal.j.0023" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Trials to make obese women comparable to normal women could be evaluated using YHL, but not YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17203" end="17209" sStart="null" offset="98" sid="r9.normal.j.0022" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Thus, an intervention to improve the health of underweight women to that of their normal weight peers could be performed using either YHL or YOL as the outcome variable." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="17026" end="17032" sStart="null" offset="23" sid="r9.normal.j.0021" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="For comparing obese to normal, only YHL for women showed a large and significant effect size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16537" end="16543" sStart="null" offset="80" sid="r9.normal.j.0020" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="The biggest effect sizes are in the first row, comparing underweight to normal." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16216" end="16222" sStart="null" offset="74" sid="r9.normal.j.0019" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15885" end="15891" sStart="null" offset="78" sid="r9.normal.j.0018" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15607" end="15613" sStart="null" offset="72" sid="r9.normal.j.0017" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="We next present the effect size for comparing each group to the normal BMI group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15414" end="15420" sStart="null" offset="67" sid="r9.normal.j.0016" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="YHL was significantly higher for women than for men in the normal and overweight groups, but the sexes had similar YHL in the underweight and obese groups." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15197" end="15203" sStart="null" offset="115" sid="r9.normal.j.0015" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="The YHL for underweight or obese women was about 4.5 years, which was significantly lower than the normal group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15029" end="15035" sStart="null" offset="15" sid="r9.normal.j.0014" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Women who were normal or overweight averaged about 4.9 YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14866" end="14872" sStart="null" offset="26" sid="r9.normal.j.0013" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Men classified as normal, overweight or obese all had about the same YOL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14790" end="14796" sStart="null" offset="108" sid="r9.normal.j.0012" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Underweight men also had lower YOL, but this group was not significantly different from the normal group, in part because of low sample size." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="14667" end="14673" sStart="null" offset="106" sid="r9.normal.j.0011" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Underweight women averaged about .25 fewer YOL than other women (p &lt; .05 compared with normal group)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="13738" end="13744" sStart="null" offset="29" sid="r9.normal.j.0010" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="5 to 20 would be considered 'normal' by the NHLBI guidelines, but had lower YOL and YHL than those with 20-24." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9536" end="9542" sStart="null" offset="112" sid="r9.normal.j.0009" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="Finally we calculated the effect size for each measure, comparing each BMI subgroup to the 'normal' group." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="3608" end="3614" sStart="null" offset="89" sid="r9.normal.j.0008" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="A report from the National Heart Lung and Blood Institute classifies normal weight (without reference to age) as a BMI of 18." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="21347" end="21351" sStart="null" offset="0" sid="null" wn="3" wnkey="lose%2:37:00::" annotator="veweser" text="Analysis of mean YOL instead of the more traditional survival analysis survival analysis was appropriate here, since virtually no persons were &lt;b&gt;lost&lt;/b&gt; to follow-up." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="21347" end="21351" sStart="null" offset="163" sid="null" wn="" wnkey="null" annotator="vebatchelder" text="Analysis of mean YOL instead of the more traditional survival analysis survival analysis was appropriate here, since virtually no persons were lost to follow-up." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="12392" end="12396" sStart="null" offset="162" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="Among females, blacks and whites differed significantly on BMI, BMI&gt;30, weight loss since age 50, YOL, YHL, years of unhealthy life, and years lost to death." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="11975" end="11979" sStart="null" offset="174" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="Among males, there were significant differences between black and white for BMI, unintended weight loss, YOL, YHL, years of unhealthy life, and years lost to death." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="11364" end="11368" sStart="null" offset="38" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="3 out of 7) while white women lost only 0.4 years." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="11286" end="11290" sStart="null" offset="157" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="White women had the most YHL and black men the fewest; black women had the most years of unhealthy life, and white men the fewest; black men lost the most years to death (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="11100" end="11104" sStart="null" offset="251" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="For example, black women averaged 6.3 YOL, but only 4.2 YHL of a maximum possible 7. We calculated some additional descriptive statistics, shown in the final two lines: years of unhealthy life (YOL minus YHL) and years lost to death (7 minus YOL)." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="10285" end="10289" sStart="null" offset="59" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="Black men were most likely to have unintentionally lost more than 10 pounds in the past year; white women were least likely." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="86" end="90" sStart="null" offset="41" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="vebatchelder" text="Older adults are frequently counseled to lose weight, even though there is little evidence that overweight is associated with increased mortality in those over age 65." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="11100" end="11104" sStart="null" offset="0" sid="null" wn="7" wnkey="lose%2:40:00::" annotator="cgozo" text="For example, black women averaged 6.3 YOL, but only 4.2 YHL of a maximum possible 7. We calculated some additional descriptive statistics, shown in the final two lines: years of unhealthy life (YOL minus YHL) and years &lt;b&gt;lost&lt;/b&gt; to death (7 minus YOL)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="11364" end="11368" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="brubin" text="3 out of 7) while white women &lt;b&gt;lost&lt;/b&gt; only 0.4 years." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="4038" end="4043" sStart="null" offset="41" sid="r8.live.v.0805" wn="1" wnkey="live%2:42:08::" annotator="veweser" text="YOL is the number of years that a person lived in the 7 years after baseline." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="4271" end="4275" sStart="null" offset="186" sid="r8.life.n.0749" wn="2147483647" wnkey="null" annotator="veweser" text="YHL is the number of years in which the person was 'healthy', and is similar in concept to quality-adjusted life-years, healthy year equivalents, or active life expectancy [ 14 ] . We based YHL on self-rated health (is your health excellent, very good, good, fair, or poor?)" />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="24090" end="24094" sStart="null" offset="13" sid="r8.life.n.0486" wn="6" wnkey="life%1:28:01::" annotator="jeneale" text="YOL Years of life" />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="822" end="826" sStart="null" offset="78" sid="r8.life.n.0240" wn="1" wnkey="life%1:26:01::" annotator="cgozo" text="Many healthy older adults report gradual weight gain throughout adult life." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="1272" end="1276" sStart="null" offset="308" sid="r8.life.n.0707" wn="1" wnkey="life%1:26:01::" annotator="brubin" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="1297" end="1301" sStart="null" offset="333" sid="r8.life.n.0147" wn="2" wnkey="life%1:09:00::" annotator="brubin" text="It has been suggested that weight standards be adjusted upwards for age [ 8 ] . Such recommendations remain controversial, however, because the number of studies of older persons is fairly small, and because few studies have examined the relation of BMI to quality of life or years of healthy life (YHL) in the elderly [ 9 ] ." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5728" end="5733" sStart="null" offset="98" sid="r9.level.n.0020" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5728" end="5733" sStart="null" offset="98" sid="r9.level.n.0020" wn="2" wnkey="level%1:26:01::" annotator="cgozo" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5728" end="5733" sStart="null" offset="98" sid="r9.level.n.0020" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="5728" end="5733" sStart="null" offset="98" sid="r9.level.n.0020" wn="3" wnkey="level%1:26:00::" annotator="anfahmy" text="We also used an alternative approach, which assigns a different value to each level of EVGFP [ 19 ] . Preliminary results were similar for the two approaches, however, and we report results using only the simpler definition." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="8447" end="8454" sStart="null" offset="80" sid="null" wn="1" wnkey="history%1:28:00::" annotator="anfahmy" text="We regressed YOL and YHL first on age, age squared, race, and smoking history (former or never), and second on all of the covariates listed above." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="7320" end="7327" sStart="null" offset="83" sid="null" wn="1" wnkey="history%1:28:00::" annotator="anfahmy" text="Self-reported covariates include age, gender, smoking (never or former), history of arthritis, cancer, diabetes, fair or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="578" end="582" sStart="null" offset="341" sid="r10.high.j.0046" wn="1" wnkey="high%3:00:02::" annotator="veweser" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="578" end="582" sStart="null" offset="341" sid="r10.high.j.0735" wn="1" wnkey="high%3:00:02::" annotator="cgozo" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="578" end="582" sStart="null" offset="341" sid="r10.high.j.0046" wn="1" wnkey="high%3:00:02::" annotator="cgozo" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="578" end="582" sStart="null" offset="341" sid="r10.high.j.0046" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="578" end="582" sStart="null" offset="341" sid="r10.high.j.0046" wn="1" wnkey="high%3:00:02::" annotator="anfahmy" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="16185" end="16189" sStart="null" offset="43" sid="r10.help.v.0228" wn="2" wnkey="help%2:29:00::" annotator="brubin" text="A clinical trial of a treatment to help underweight women achieve normal weight (presumably by addressing the underlying cause) could be expected to have 80% power with N = (1." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22972" end="22977" sStart="null" offset="11" sid="null" wn="4" wnkey="find%2:32:00::" annotator="veweser" text="We found associations between YHL and obesity that were not present in the mortality analysis, suggesting that YHL may be a more sensitive measure of the burden of obesity in older adults, especially for women." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="480" end="485" sStart="null" offset="243" sid="r10.find.v.0205" wn="4" wnkey="find%2:32:00::" annotator="veweser" text="Six large controlled population-based studies of non-smoking older adults have investigated the association between body mass index (BMI) and mortality, controlling for relevant covariates [ 1 2 3 4 5 6 ] . All studies found excess risk for persons with very low BMI, but that persons with moderately high BMI had little or no extra risk except in certain small subsets." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19937" end="19942" sStart="null" offset="80" sid="r10.find.v.0014" wn="4" wnkey="find%2:32:00::" annotator="veweser" text="This is particularly important in the light of recent findings, which found that interventions such as weight-loss drugs may be harmful [ 33 34 ] . For older adults, the risks associated with higher weight are especially unclear, and the optimal outcome for a trial of weight loss in older adults requires specific attention to improved health and mortality." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22972" end="22977" sStart="null" offset="11" sid="null" wn="9" wnkey="find%2:31:09::" annotator="cgozo" text="We found associations between YHL and obesity that were not present in the mortality analysis, suggesting that YHL may be a more sensitive measure of the burden of obesity in older adults, especially for women." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22972" end="22977" sStart="null" offset="11" sid="r10.find.v.0207" wn="2" wnkey="find%2:39:02::" annotator="cgozo" text="We found associations between YHL and obesity that were not present in the mortality analysis, suggesting that YHL may be a more sensitive measure of the burden of obesity in older adults, especially for women." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19937" end="19942" sStart="null" offset="80" sid="r10.find.v.0014" wn="8" wnkey="find%2:36:00::" annotator="cgozo" text="This is particularly important in the light of recent findings, which found that interventions such as weight-loss drugs may be harmful [ 33 34 ] . For older adults, the risks associated with higher weight are especially unclear, and the optimal outcome for a trial of weight loss in older adults requires specific attention to improved health and mortality." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22972" end="22977" sStart="null" offset="11" sid="null" wn="4" wnkey="find%2:32:00::" annotator="brubin" text="We found associations between YHL and obesity that were not present in the mortality analysis, suggesting that YHL may be a more sensitive measure of the burden of obesity in older adults, especially for women." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="23345" end="23350" sStart="null" offset="37" sid="r10.find.v.0208" wn="8" wnkey="find%2:36:00::" annotator="brubin" text="Using either YOL or YHL, however, we found no excess risk for older adults who would be classified as 'overweight' by the NHLBI guidelines." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19937" end="19942" sStart="null" offset="80" sid="r10.find.v.0014" wn="8" wnkey="find%2:36:00::" annotator="brubin" text="This is particularly important in the light of recent findings, which found that interventions such as weight-loss drugs may be harmful [ 33 34 ] . For older adults, the risks associated with higher weight are especially unclear, and the optimal outcome for a trial of weight loss in older adults requires specific attention to improved health and mortality." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22972" end="22977" sStart="null" offset="11" sid="null" wn="2" wnkey="find%2:39:02::" annotator="anfahmy" text="We found associations between YHL and obesity that were not present in the mortality analysis, suggesting that YHL may be a more sensitive measure of the burden of obesity in older adults, especially for women." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="20361" end="20366" sStart="null" offset="65" sid="r10.find.v.0206" wn="4" wnkey="find%2:32:00::" annotator="anfahmy" text="Interestingly, the strongest health relationships were found for underweight older adults." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19937" end="19942" sStart="null" offset="80" sid="r10.find.v.0014" wn="4" wnkey="find%2:32:00::" annotator="anfahmy" text="This is particularly important in the light of recent findings, which found that interventions such as weight-loss drugs may be harmful [ 33 34 ] . For older adults, the risks associated with higher weight are especially unclear, and the optimal outcome for a trial of weight loss in older adults requires specific attention to improved health and mortality." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tlippincott" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="2147483646" wnkey="null" annotator="rstandig" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="4394" end="4398" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="kaolla" text="YHL is the number of years in which the person was 'healthy', and is similar in concept to quality-adjusted life-years, healthy year equivalents, or active life expectancy [ 14 ] . We based YHL on self-rated health (is your health excellent, very good, good, &lt;b&gt;fair&lt;/b&gt;, or poor?)" />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="kaolla" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="7370" end="7374" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="kaolla" text="Self-reported covariates include age, gender, smoking (never or former), history of arthritis, cancer, diabetes, &lt;b&gt;fair&lt;/b&gt; or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="10553" end="10557" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="elstickles" text="Of the 22% who were unhealthy (&lt;b&gt;fair&lt;/b&gt; or poor) at baseline, about 24% were healthy 7 years later." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="elstickles" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="comcgeetubb" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="cgozo" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="4394" end="4398" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="YHL is the number of years in which the person was 'healthy', and is similar in concept to quality-adjusted life-years, healthy year equivalents, or active life expectancy [ 14 ] . We based YHL on self-rated health (is your health excellent, very good, good, &lt;b&gt;fair&lt;/b&gt;, or poor?)" />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="7370" end="7374" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="Self-reported covariates include age, gender, smoking (never or former), history of arthritis, cancer, diabetes, &lt;b&gt;fair&lt;/b&gt; or poor self-rated health status, limitations in activities of daily living or in instrumental activities of daily living, and 10 pounds or more unintended weight loss in the year before baseline." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="10553" end="10557" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="Of the 22% who were unhealthy (&lt;b&gt;fair&lt;/b&gt; or poor) at baseline, about 24% were healthy 7 years later." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="23972" end="23976" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="EVGFP Is your health excellent, very good, good, &lt;b&gt;fair&lt;/b&gt; or poor?" />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="carichter" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-1.anc" start="5549" end="5553" sStart="null" offset="0" sid="null" wn="5" wnkey="fair%5:00:00:ordinary:00" annotator="brubin" text="A drawback of this simple definition of 'healthy' is that it does not distinguish between &lt;b&gt;fair&lt;/b&gt; or poor health and death, since all are considered 'not healthy'." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19638" end="19646" sStart="null" offset="126" sid="null" wn="1" wnkey="exercise%1:04:00::" annotator="sophiavv" text="Weight or weight change are sometimes used as the outcome in evaluations of interventions such as diet or exercise programs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="19638" end="19646" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" annotator="cgozo" text="Weight or weight change are sometimes used as the outcome in evaluations of interventions such as diet or &lt;b&gt;exercise&lt;/b&gt; programs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="19638" end="19646" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" annotator="brubin" text="Weight or weight change are sometimes used as the outcome in evaluations of interventions such as diet or &lt;b&gt;exercise&lt;/b&gt; programs." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="13354" end="13363" sStart="null" offset="91" sid="r8.1.different.j.0020" wn="2" wnkey="different%5:00:00:other:00" annotator="veweser" text="9. The second column, which shows results adjusted for all covariates, is not very different (the only discrepancy is for men with BMI &lt; 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="13354" end="13363" sStart="null" offset="91" sid="r8.1.different.j.0020" wn="1" wnkey="different%3:00:00::" annotator="jeneale" text="9. The second column, which shows results adjusted for all covariates, is not very different (the only discrepancy is for men with BMI &lt; 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="13354" end="13363" sStart="null" offset="91" sid="r8.1.different.j.0020" wn="1" wnkey="different%3:00:00::" annotator="cgozo" text="9. The second column, which shows results adjusted for all covariates, is not very different (the only discrepancy is for men with BMI &lt; 18." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="17789" end="17798" sStart="null" offset="130" sid="r8.1.different.j.0167" wn="1" wnkey="different%3:00:00::" annotator="brubin" text="As mentioned above, we repeated these analyses excluding the persons with partially estimated data, and using two different ways of coding YHL." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="13354" end="13363" sStart="null" offset="91" sid="r8.1.different.j.0020" wn="1" wnkey="different%3:00:00::" annotator="brubin" text="9. The second column, which shows results adjusted for all covariates, is not very different (the only discrepancy is for men with BMI &lt; 18." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18781" end="18792" sStart="null" offset="23" sid="null" wn="" wnkey="null" annotator="ksuderman" text="This suggests that the development of future guidelines should take YHL or other measures of quality of life into account." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="18781" end="18792" sStart="null" offset="23" sid="null" wn="1" wnkey="development%1:04:01::" annotator="anfahmy" text="This suggests that the development of future guidelines should take YHL or other measures of quality of life into account." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="veweser" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="veweser" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="161" sid="null" wn="4" wnkey="date%1:28:02::" annotator="vebatchelder" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to date." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="3223" end="3227" sStart="null" offset="165" sid="null" wn="4" wnkey="date%1:28:02::" annotator="vebatchelder" text="Two cohorts were followed, one with 7 years of follow-up (n = 5,201) and the second (all African American, n = 687) with 4 years of follow-up to date." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="jeneale" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="a4" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="a3" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="a2" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-1.anc" start="6066" end="6070" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" annotator="a1" text="The calculations had to be modified to include the 438 persons in the second African American cohort, who have been followed only 4 years to &lt;b&gt;date&lt;/b&gt;." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="null" wn="3" wnkey="common%5:00:00:shared:00" annotator="veweser" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="r10.common.j.0015" wn="4" wnkey="common%5:00:00:familiar:02" annotator="veweser" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9657" end="9663" sStart="null" offset="106" sid="r10.common.j.0014" wn="4" wnkey="common%5:00:00:familiar:02" annotator="veweser" text="The effect size is the difference in mean YOL (or YHL) in two groups divided by their common standard deviation." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="null" wn="2147483646" wnkey="null" annotator="cgozo" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="r10.common.j.0015" wn="4" wnkey="common%5:00:00:familiar:02" annotator="cgozo" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9657" end="9663" sStart="null" offset="106" sid="r10.common.j.0014" wn="4" wnkey="common%5:00:00:familiar:02" annotator="cgozo" text="The effect size is the difference in mean YOL (or YHL) in two groups divided by their common standard deviation." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="null" wn="9" wnkey="common%5:00:00:ordinary:00" annotator="brubin" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="r10.common.j.0015" wn="3" wnkey="common%5:00:00:shared:00" annotator="brubin" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9657" end="9663" sStart="null" offset="106" sid="r10.common.j.0014" wn="3" wnkey="common%5:00:00:shared:00" annotator="brubin" text="The effect size is the difference in mean YOL (or YHL) in two groups divided by their common standard deviation." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="null" wn="4" wnkey="common%5:00:00:familiar:02" annotator="anfahmy" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="15907" end="15913" sStart="null" offset="100" sid="r10.common.j.0015" wn="3" wnkey="common%5:00:00:shared:00" annotator="anfahmy" text="For example, underweight women averaged 4.50 YHL compared to 4.92 for normal women, and the common standard deviation was 1.44." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="9657" end="9663" sStart="null" offset="106" sid="r10.common.j.0014" wn="3" wnkey="common%5:00:00:shared:00" annotator="anfahmy" text="The effect size is the difference in mean YOL (or YHL) in two groups divided by their common standard deviation." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19373" end="19379" sStart="null" offset="123" sid="r9.appear.v.0079" wn="1" wnkey="appear%2:39:00::" annotator="veweser" text="Clinical trials of weight modification interventions for older adults who were merely overweight would appear to be fruitless since the interventions would probably not have a direct effect on either YOL or YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19373" end="19379" sStart="null" offset="123" sid="r9.appear.v.0079" wn="4" wnkey="appear%2:39:01::" annotator="cgozo" text="Clinical trials of weight modification interventions for older adults who were merely overweight would appear to be fruitless since the interventions would probably not have a direct effect on either YOL or YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19373" end="19379" sStart="null" offset="123" sid="r9.appear.v.0079" wn="1" wnkey="appear%2:39:00::" annotator="brubin" text="Clinical trials of weight modification interventions for older adults who were merely overweight would appear to be fruitless since the interventions would probably not have a direct effect on either YOL or YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="19373" end="19379" sStart="null" offset="123" sid="r9.appear.v.0079" wn="1" wnkey="appear%2:39:00::" annotator="anfahmy" text="Clinical trials of weight modification interventions for older adults who were merely overweight would appear to be fruitless since the interventions would probably not have a direct effect on either YOL or YHL." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="21816" end="21819" sStart="null" offset="119" sid="null" wn="3" wnkey="add%2:40:00::" annotator="vebatchelder" text="The effect sizes in Table 3might also be appropriate in shorter trials, since lengthy trials often add little information [ 10 ] ." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="4694" end="4699" sStart="null" offset="230" sid="null" wn="2147483646" wnkey="null" annotator="vebatchelder" text="EVGFP is a simple but well-known measure, which has been studied in detail [ 15 16 ] , and is predictive of health events in many studies [ 17 ] . Because we are examining health status over time, we added a sixth health state, dead." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="r11.absence.n.0005" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="null" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="r11.absence.n.0120" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
    <s path="[MASC]/data/written/1468-6708-3-1.anc" start="22752" end="22759" sStart="null" offset="177" sid="r11.absence.n.0005" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="These more sensitive measures might also have detected differences between the overweight and normal weight persons, but we think this is unlikely given the absence of any differences in EVGFP." />
  </sentences>
</list>